Anticoagulants for stroke prevention in nonvalvular atrial fibrillation: new agents and an updated understanding.
Year: 2012
Type: article
Abstract: Atrial fibrillation (AF) is the most common cardiac arrhythmia, accounting for up to one third of arrhythmia-related hospital admissions. The Centers for Disease Control estimates the prevalence of AF in the American population to be 2.66 million people, representing 0.4% to 1% of the general population. The incidence of AF, as suggested by prospective data, is 80 years of age, respectively.1 Stroke is the most feared consequence of AF, and its incidence increases drastically with advancing age. Stroke is the number-one cause of long-term disability and the third-leading cause of death in patients with AF.
Source: Europe PMC (PubMed Central)
Authors: Leila Ganjehei, James M Wilson
Institution: Baylor St. Luke's Medical Center
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W1598509721